Skip to main content
Egyptian Journal of Medical Human Genetics

Table 2 Serum level of soluble HLA-G antigens in inflammatory bowel disease (ulcerative colitis and Crohn's disease) patients and controls

From: Susceptibility role of soluble HLA-G and HLA-G 14-bp insertion/deletion polymorphism in inflammatory bowel disease

Group

sHLA-G (mean ± SD); ng/ml

p1

p2

Controls (N = 30)

126.8 ± 15.1

  

IBD (N = 60)

174.7 ± 27.1

< 0.001

 

UC (N = 30)

180.5 ± 27.1

< 0.001

0.059

CD (N = 30)

168.9 ± 26.3

< 0.001

 
  1. Significant p is bold-marked
  2. IBD inflammatory bowel disease, UC ulcerative colitis, CD Crohn’s disease, p1 LSD (least significant difference) probability compared to control, p2 UC vs. CD
Back to article page